Pfizer's pediatric Covid vaccine, the only one available for children under five, may not receive renewal from the FDA this fall. The FDA recently informed Pfizer of this possibility, as stated in an email from the NCIRD. This decision could limit vaccine access significantly, as Moderna's vaccine is currently approved only for children with health conditions. Discussions are ongoing between the CDC and Moderna about increasing supply to meet potential shortages. The situation raises concerns regarding the vaccination options for young children and public health responses.
Pfizer's Covid vaccine for young children may not be renewed by the FDA this fall, leading to a gap in available vaccines for those under five.
According to an email from the NCIRD, Pfizer has been informed that the FDA may not renew the emergency use authorization for its pediatric Covid vaccine.
Moderna is in talks with the CDC to rapidly increase the supply of its Covid vaccine for young children, focusing on planning around volume and timing.
The only available Covid vaccines for children remain limited, with Moderna approved only for those with health conditions and Novavax for ages 12 and up.
Collection
[
|
...
]